Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018102174) TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2018/102174 International Application No.: PCT/US2017/062526
Publication Date: 07.06.2018 International Filing Date: 20.11.2017
IPC:
A61K 35/51 (2015.01) ,A61K 9/00 (2006.01) ,A61K 45/06 (2006.01)
[IPC code unknown for A61K 35/51]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants:
JANSSEN BIOTECH, INC. [US/US]; 800/850 Ridgeview Drive Horsham, Pennsylvania 19044, US
Inventors:
HARRIS, Ian R.; US
CAO, Jing; US
DEJNEKA, Nadine; US
Agent:
SHIRTZ, Joseph F.; US
WARFIELD, Mark R.; US
Priority Data:
15/366,94701.12.2016US
Title (EN) TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
(FR) TRAITEMENT DE LA DÉGÉNÉRESCENCE RÉTINIENNE À L'AIDE DE CELLULES PROGÉNITRICES
Abstract:
(EN) Methods and compositions for treating and reducing retinal degeneration using progenitor cells and conditioned media from progenitor cells, such as postpartum-derived cells are disclosed. Trophic factors and other agents secreted by the progenitor cells that protect retinal cells and inhibit apoptosis of retinal cells such as photoreceptor cells are also disclosed.
(FR) L'invention concerne des méthodes et des compositions destinées à traiter et à réduire la dégénérescence rétinienne à l'aide de cellules progénitrices et de milieux conditionnés issus de cellules progénitrices, telles que les cellules dérivées du post-partum. L'invention concerne également des facteurs trophiques et d'autres agents sécrétés par les cellules progénitrices qui protègent les cellules rétiniennes et inhibent l'apoptose de cellules rétiniennes, telles que des cellules photoréceptrices.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)